Indications: FDA approved: Type II diabetes - monotherapy or combination therapy Can be combined as adjunct therapy with other hypoglycemics including metformin, thiazolidinediones, or insulin regimens (Dungan & DeSantis 2015) Because it does not work when your blood sugar is low, it is unlikely to produce dangerous levels of hypoglycemia has been observed in clinical trials (in contrast to GLP-1 incretin mimetics, such as exenatide, which produce moderate weight loss)
What recent regulatory changes have impacted diabetes medication accessibility in South Korea?
A controlled human intervention study further demonstrated immunological benefits of whole shiitake consumption
Mayraki formulas are designed to support stimulate hair follicles, promote healthy hair growth, and improve overall hair quality
Nagashima, M
Cerovecki T, Bojanic I, Brcic L, et al